Top Biotechnology companies in Germany by EBIT

This ranking features the top 18 Biotechnology companies in Germany ranked by EBIT, totaling a EBIT of USD 11.49 B, for July 05, 2025.

#	Name	Market Capitalization Share Price Year-To-Date (YTD) return Price to Earnings Ratio (P/E) Revenue Revenue Year-on-Year (YoY) growth Operating Income EBITDA Free Cash Flow Dividend Yield Free Cash Flow Yield Total Assets Total Liabilities Cash and Short-Term Investments	Stock Price	Change	Price (30 days)	52W low/high	Sector

Items per page

Frequently Asked Questions

Which Biotechnology company in Germany has the highest EBIT ?

The Biotechnology company in Germany with the highest EBIT is Bayer AG (XETRA: BAYN.DE) at USD 4.93 B.

Which Biotechnology company in Germany has the lowest EBIT ?

The Biotechnology company in Germany with the lowest EBIT is Atai Life Sciences N.V. (NasdaqGM: ATAI) at None.

What are the top 10 Biotechnology companies in Germany by EBIT ?

The top 10 Biotechnology companies in Germany by EBIT are Bayer AG, MERCK Kommanditgesellschaft auf Aktien, Siemens Healthineers AG, CureVac N.V., Biotest AG, Eckert & Ziegler Strahlen- und Medizintechnik AG, Stratec SE, Anbio Biotechnology Class A Ordinary Shares, VITA 34 AG and BRAIN Biotech AG.

What are the bottom 10 Biotechnology companies in Germany by EBIT ?

The bottom 10 Biotechnology companies in Germany by EBIT are Atai Life Sciences N.V., BioNTech SE, Evotec SE, Formycon AG, Vivoryon Therapeutics N.V., Mainz Biomed B.V., Heidelberg Pharma AG, Immatics N.V., BRAIN Biotech AG and VITA 34 AG.